Literature DB >> 30675038

Correction: Association of ACE2 genetic polymorphisms with hypertension-related target organ damages in south Xinjiang.

Yi Luo1, Cheng Liu2,3,4, Tianwang Guan5, Yanfang Li5, Yanxian Lai1, Fang Li6, Haiyan Zhao6, Tutiguli Maimaiti6, Abudurexiti Zeyaweiding6.   

Abstract

The version of this article originally published was not open access. This article should have been open access. The error has been fixed, and the article is now open access.

Entities:  

Year:  2019        PMID： 30675038     DOI： 10.1038/s41440-019-0205-y

Source DB:  PubMed          Journal:  Hypertens Res        ISSN： 0916-9636            Impact factor:   3.872


  3 in total

Review 1.  The Yin and Yang of ACE/ACE2 Pathways: The Rationale for the Use of Renin-Angiotensin System Inhibitors in COVID-19 Patients.

Authors:  Loris Zamai
Journal:  Cells       Date:  2020-07-16       Impact factor: 6.600

2.  Human Ace D/I Polymorphism Could Affect the Clinicobiological Course of COVID-19.

Authors:  Elifcan Aladag; Zahit Tas; Bilgesu Safak Ozdemir; Tayfun Hilmi Akbaba; Meltem Gulsun Akpınar; Hakan Goker; Tugce Unalan-Altintop; Ahmet Cagkan Inkaya; Alpaslan Alp; Gokhan Metan; Ibrahim Celalettin Haznedaroglu; Banu Balci-Peynircioglu; Nilgun Sayinalp
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2021-09-15       Impact factor: 1.636

Review 3.  COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy?

Authors:  A Aleksova; F Ferro; G Gagno; C Cappelletto; D Santon; M Rossi; G Ippolito; A Zumla; A P Beltrami; G Sinagra
Journal:  J Intern Med       Date:  2020-06-08       Impact factor: 13.068
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.